Dec. 28, 2020

IR

Myovant, Consolidated Subsidiary of Sumitomo Dainippon Pharma, and Pfizer Enter Into Collaboration to Develop and Commercialize Relugolix

Dec. 18, 2020

Announcements

Q&A Summary of "IR Day" has been published

Dec. 14, 2020

Announcements

IR Day has been released.

Nov. 4, 2020

Announcements

Q&A Summary of "ESG Meeting" has been published

Oct. 30, 2020

IR

Sumitomo Chemical Reports Consolidated Financial Results For the Half-Year Ended September 30, 2020

Oct. 30, 2020

IR

Sumitomo Chemical Announces Revisions to Its Financial Forecast for the Full Year Ending March 31, 2021

Oct. 30, 2020

IR

Sumitomo Chemical Reports Unrealized Losses on Securities as of September 30, 2020

Oct. 27, 2020

Announcements

ESG Meeting has been released.

Oct. 1, 2020

IR

Termination of Completion Guarantee for Rabigh Phase 2 Project Financing

Sep. 30, 2020

Announcements

Annual Report 2020 has been published

Aug. 4, 2020

IR

Consolidated Financial Results for the 1st Quarter ended June 30, 2020 has been published

Aug. 4, 2020

IR

Sumitomo Chemical Reports Unrealized Losses on Securities as of June 30, 2020

Jun. 19, 2020

Announcements

Q&A Summary of "Current Priority Management Issues and Business Strategy" has been published

Jun. 4, 2020

Announcements

Notice of the 139th Ordinary General Meeting of Shareholders has been published

May. 29, 2020

Announcements

Investors' Handbook 2020 has been published

May. 15, 2020

IR

Sumitomo Chemical Announces Consolidated Financial Results for FY2019

May. 15, 2020

IR

Sumitomo Chemical Reports Unrealized Losses on Securities as of March 31, 2020

May. 1, 2020

Announcements

Sumitomo Chemical Removes Itself from the Moody's Credit Rating List

Feb. 28, 2020

IR

Sumitomo Chemical Announces Revisions to Its Financial Forecast and Projected Dividend for the Full Year Ending March 31, 2020

Jan. 31, 2020

IR

Consolidated Financial Results for the 3rd Quarter ended December 31, 2019 has been published